pharmacological antagonists and agonists. Materials and
methods: We conducted 3 sets of experiments in white
of some preclinical and clinical studies. Material and
methods For a comprehensive search, we used
Shnayder, N.A.,
Novitsky, M.A.,
Neznanov, N.G.,
Limankin, O.V.,
Asadullin, A.R.,
Petrov, A.V.,
Dmitrenko, D.V.,
Narodova, E.A.,
Popenko, N.V.,
Nasyrova, R.F. (2022) the potential genetic predictors of schizophrenia and depression comorbidity. Materials and
Methods: We carried
articles and literature reviews on in vivo, in vitro and ex vivo experiments.
Methods: The current
Sufianova, Galina,
Sufianova, Galina,
Beylerli, Ozal,
Wu, Jianing,
Shumadalova, Alina,
Sufianov, Albert,
Chen, Xin,
Zhao, Shiguang (2022) methods for the prevention and treatment of tumors. Copyright © 2022 Sufianova, Gareev, Beylerli, Wu
in massive blood loss.
Methods: The temperature change in the fingertips before and after the application
of neuropharmacological interaction.
Materials and
methods: To study the mechanism of action of N-199/1, its effect on 5
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) using up-to-date hygienic, clinical-laboratory and genetic
methods. The study included hygienic